CD81 as a tumor target
Authors:
- 13 April 2017
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 45 (2) , 531-535
Abstract
CD81 participates in a variety of important cellular processes such as membrane organization, protein trafficking, cellular fusion and cell–cell interactions. In the immune system, CD81 regulates immune synapse, receptor clustering and signaling; it also mediates adaptive and innate immune suppression. CD81 is a gateway in hepatocytes for pathogens such as hepatitis C virus and Plasmodium; it also confers susceptibility to Listeria infection. These diverse biological roles are due to the tendency of CD81 to associate with other tetraspanins and with cell-specific partner proteins, which provide the cells with a signaling platform. CD81 has also been shown to regulate cell migration and invasion, and has therefore been implicated in cancer progression. Indeed, we have recently shown that CD81 contributes to tumor growth and metastasis. CD81 is expressed in most types of cancer, including breast, lung, prostate, melanoma, brain cancer and lymphoma, and the overexpression or down-regulation of this molecule has been correlated with either good or bad prognosis. Here, we discuss the role of CD81 in cancer and its potential therapeutic use as a tumor target.Keywords
This publication has 37 references indexed in Scilit:
- Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81Proceedings of the National Academy of Sciences, 2012
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin LymphomaCell, 2010
- CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomasHuman Pathology, 2010
- Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actinJournal of Cell Science, 2009
- Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular CarcinomaGastroenterology, 2008
- Reduced fertility of female mice lacking CD81Developmental Biology, 2006
- Normal Lymphocyte Development but Delayed Humoral Immune Response in CD81-null MiceJournal of Experimental Medicine, 1997
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995
- Identification of rare immunoglobulin switch variants using the ELISA spot assayJournal of Immunological Methods, 1992
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975